Android app on Google Play

Teva Pharmaceutical (TEVA) Slammed Early on FY13 Warning

November 30, 2012 7:20 AM EST Send to a Friend
Get Alerts TEVAQ Hot Sheet
Price: $0.00 --0%

Today's EPS Names:
LNG, BFS, CPT, More
Trade TEVAQ Now!
Join SI Premium – FREE
Teva Pharmaceutical Industries (NYSE: TEVA) is trading down 5.3 percent following lower guidance announced moments ago.

Teva Pharmaceutical said it expects FY13 adjusted EPS of $4.85 - $5.15, versus the consensus of $5.63. The company is targeting revs of $19.5 - $20.5 billion, versus the consensus of $20.82 billion.




You May Also Be Interested In


Related Categories

Guidance, Hot Guidance, Trader Talk

Add Your Comment